Stocks to keep an eye on March 18, 2015

( click to enlarge )
FireEye Inc (NASDAQ:FEYE) is bullishly flagging off its upmove from the 36 area to around 46.50 and could see 46/48 if it breaks above 43.48. A/D is increasing indicating accumulation of shares in the market. As long as the stock holds above the 40.78 support level the intermediate-term picture should remain positive. Fresh exposures may be considered on a move past $43.48.

( click to enlarge )
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) In the past few days we have noticed that the stock price has been on a consistent bullish uptick in market valuation. Moreover, along with the market valuation the technical daily indicators MACD, RSI and A/D have been bullish, rising for the past several days. Additionally, the stock past a key resistance level of 4.73. So, keep watching ARNA trade and watch for potential continuation of its recent upward move.

( click to enlarge )
Second Sight Medical Products Inc (NASDAQ:EYES) Looking at the hourly chart above, the stock has just started moving higher and established a short term up-trend above its 200-day EMA. This could be the start of a nice rebound. Nearest resistance for the stock is at $14.50. If this level is crossed and the stock is able to sustain above this level, then it might go to $17.

( click to enlarge )
I have Adamas Pharmaceuticals Inc (NASDAQ:ADMS) on my watchlist. It may be ready to break out of this large consolidation. Bullish MACD cross on daily. Potential swing long above 18

Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

AC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.